Immunomedics being invesigated

Levi & Korsinky initiated an investigation into possible securities violations by the Immunomedics Inc. (Nasdaq: IMMU) Board of Directors sending the stock price plummeting $1.16 to close at $2.55.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.